Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.746194
Keywords
NREP; gastric cancer; bioinformatics; epithelial-mesenchymal transition; cancer-associated fibroblasts; M2 macrophages
Categories
Ask authors/readers for more resources
This study demonstrates that overexpression of NREP in gastric cancer is associated with poor prognosis, potentially influencing the activation of cancer-associated fibroblasts and epithelial-mesenchymal transition. Additionally, the expression of NREP correlates with the abundance of M2 macrophages, suggesting it could serve as a prognostic biomarker and therapeutic target for gastric cancer.
The identification of biomarkers and effective therapeutic targets for gastric cancer (GC), the most common cause of cancer-related deaths around the world, is currently a major focus area in research. Here, we examined the utility of Neuronal Regeneration Related Protein (NREP) as a prognostic biomarker and therapeutic target for GC. We assessed the clinical relevance, function, and molecular role of NREP in GC using bioinformatics analysis and experimental validation. Our results showed that in GC, NREP overexpression was significantly associated with a poor prognosis. Our findings also suggested that NREP may be involved in the activation of cancer-associated fibroblasts and the epithelial-mesenchymal transition (EMT), with transforming growth factor beta 1 mediating both processes. In addition, NREP expression showed a positive correlation with the abundance of M2 macrophages, which are potent immunosuppressors. Together, these results indicate that NREP is overexpressed in GC and affects GC prognosis. Thus, NREP could be a prognostic biomarker and therapeutic target for GC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available